Summit Therapeutics Inc. (SMMT) quarterly cash flow statement — complete operating, investing & financing history
Summit Therapeutics Inc. (SMMT) cash flow statement — 23-year operating, investing & financing cash flows
| Metric | Q3'26 | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 |
|---|
| Cash from Operations | -159.81M | -167.78M | -92.74M | -75.65M | -69.19M | -48.97M | -47.38M | -38.89M | -23.11M | -26.07M | -24.01M | -15.4M | -12.25M | -23.11M | -10.62M | 4.23M | -7.73M | -15.83M | -14.48M | -6.8M |
| Operating CF Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -3925.16% | -8199.08% | -7607.26% | -3665.92% |
| Operating CF Growth % | -130.98% | -242.59% | -95.75% | -94.51% | -199.34% | -87.84% | -97.36% | -152.58% | -88.77% | -12.82% | -126.04% | -463.9% | -58.35% | -46% | 26.64% | 162.19% | 55.67% | -14.03% | 3.19% | -16.22% |
| Net Income | -208.38M | -261.47M | -143.65M | -162.66M | -172.3M | -415.09M | -48.73M | -48.91M | -42.92M | -47.7M | -34.63M | -28.94M | -17.48M | -11.62M | -438.68M | -15.68M | -19.33M | -13.81M | -16.3M | -20.09M |
| Depreciation & Amortization | 85K | 46K | 44K | 42K | 42K | 37K | 25K | 22K | 20K | 20K | 21.51K | 478.77K | 26.3K | 36.31K | 72.79K | 485.86K | 643.57K | 486.79K | 468.6K | 497.4K |
| Stock-Based Compensation | 47.69M | 86.3M | 55.2M | 82.96M | 97.2M | 351.31M | 8.59M | 8.8M | 14.78M | 8.76M | 7.57M | 6.93M | 579.5K | 1.48M | 2.24M | 2.17M | 2.53M | 2.06M | 3.04M | 4.17M |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | -3.93M | 3.19M | -3.06M | -2.18M | 25.64K | -935.84K | -2.48M | 1.74M | -1.84M | 10.49M | -313.08K | -447.91K | 1.2M | -2.68M | 425.89M | 7.34M | 1.64M | 1.71M | 941K | 731.64K |
| Working Capital Changes | 4.73M | 4.17M | -1.27M | 6.19M | 5.84M | 15.71M | -4.79M | -548.17K | 6.84M | 2.37M | 3.34M | 6.58M | 3.44M | -10.33M | -148.01K | 9.92M | 6.78M | -6.26M | -2.63M | 7.89M |
| Change in Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -162.22K | 198.36K | -121.66K | 503.48K | -140.86K | 2.84M | 41.84K | 970.58K | 8.72M | -19.89K | -45.3K | -922.72K | 4.84M |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | 9.82M | -2.26M | 5.16M | -1.59M | -623.67K | 13.16M | 275.74K | 1.22M | -138.09K | -2.4M | 2.95M | -531.79K | 1.92M | 234.46K | 249.12K | -1.93M | -941.86K | -2.87M | 2.1M | -1.01M |
| Cash from Investing | -204.16M | 222.84M | -180.49K | -360.06M | -52.78K | 110.66M | 124.01M | 66.71M | -82.87M | -158.06M | 15.83M | 47.93M | -2.87M | 163.41K | -521.74M | 8.15K | 18.08K | -241.34K | -275.06K | -88.95K |
| Capital Expenditures | -396K | -968.2K | -185.8K | -121.71K | -52.78K | 0 | -326.86K | -11.19K | -44.25K | -49.77K | -3.19K | -1.58K | -43.56K | -15.79K | -42.87K | 8.15K | 18.08K | -241.34K | -275.06K | -88.95K |
| CapEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 9.18% | 125.01% | 144.53% | 47.93% |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -11.45M | 0 | 0 | 0 | 0 | 178.41K | -384.2M | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | 95.43M | 456.53M | 2.88M | 425.87M | 25.13M | 1.63M | 5.95M | -18.87M | 155.75M | 158.17M | 386.38K | 4.95M | 188.24K | -63.16K | 64.8M | 423.95M | 67.79M | 0 | 19.19M | 934.75K |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -19.58M | -57.6M | 0 | 0 | 0 | 0 | 0 | -19.97M | 423.9M | -22.6M | 0 | 19.05M | 0 |
| Equity Issued (Net) | 95.43M | 224.53M | 2.88M | 425.87M | 25.13M | 1.63M | 5.95M | 709.59K | 213.35M | 158M | 0 | 3.96M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | 232M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 167.48K | 386.38K | 990.77K | 188.24K | -63.16K | 84.76M | 48.91K | 90.39M | 0 | 142.48K | 934.75K |
| Net Change in Cash | -268.56M | 511.58M | -90.06M | -9.87M | -44.09M | 63.36M | 82.61M | 8.86M | 49.85M | -25.96M | -7.82M | 37.69M | -15.06M | -22.78M | -467.2M | 429.31M | 58.42M | -16.57M | 4.31M | -6.27M |
| Free Cash Flow | -160.21M | -168.75M | -92.93M | -75.78M | -69.24M | -48.97M | -47.7M | -38.91M | -23.16M | -26.12M | -24.01M | -15.4M | -12.29M | -23.13M | -10.66M | 4.24M | -7.71M | -16.07M | -14.75M | -6.89M |
| FCF Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -3915.98% | -8324.09% | -7751.79% | -3713.85% |
| FCF Growth % | -131.37% | -244.57% | -94.8% | -94.77% | -198.99% | -87.48% | -98.69% | -152.62% | -88.46% | -12.96% | -125.16% | -463.24% | -59.29% | -43.9% | 27.72% | 161.51% | 55.76% | -14.87% | 1.54% | -17% |
| FCF per Share | -0.20 | -0.22 | -0.12 | -0.10 | -0.09 | -0.07 | -0.06 | -0.05 | -0.03 | -0.04 | -0.03 | -0.02 | -0.02 | -0.03 | -0.03 | 0.02 | -0.05 | -0.16 | -0.15 | -0.07 |
| FCF Conversion (FCF/Net Income) | 0.77x | 0.78x | 0.49x | 0.35x | 0.30x | 0.12x | 0.97x | 0.80x | 0.55x | 0.55x | 0.70x | 0.54x | 0.70x | 1.99x | 0.02x | -0.27x | 0.40x | 1.15x | 0.89x | 0.34x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 7.3M | 0 | 0 | 1.5M | 2.94M | 2.92M | 3.49M | 1.31M | 0 | 434K | 0 | 0 | 82K |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1K |